Review of Routine Laboratory Monitoring for Patients with Rheumatoid Arthritis Receiving Biologic or Nonbiologic DMARDs

Safety concerns associated with many drugs indicated for the treatment of rheumatoid arthritis (RA) can be attenuated by the early identification of toxicity through routine laboratory monitoring; however, a comprehensive review of the recommended monitoring guidelines for the different available RA...

Descripción completa

Detalles Bibliográficos
Autores principales: Rigby, William F. C., Lampl, Kathy, Low, Jason M., Furst, Daniel E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2017
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5684575/
https://www.ncbi.nlm.nih.gov/pubmed/29225625
http://dx.doi.org/10.1155/2017/9614241

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5684575/
https://www.ncbi.nlm.nih.gov/pubmed/29225625
http://dx.doi.org/10.1155/2017/9614241

Ejemplares similares